Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Juan F. Gallegos‐Orozco, Velimir A. Luketic et al.|Gastroenterology|2016Cited by 1k
The interleukin-17 pathway is involved in human alcoholic liver disease # †Arnaud Lemmers, Jacques Devière, Christophe Moreno et al.|Hepatology|2008Cited by 385
Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liverThierry Gustot, Olivier Le Moine, Arnaud Lemmers et al.|Hepatology|2006Cited by 237
Invasive aspergillosis in patients with severe alcoholic hepatitisThierry Gustot, Christophe Moreno, Evelyne Maillart et al.|Journal of Hepatology|2013Cited by 149
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver diseaseEric Trépo, Christophe Moreno, Thierry Gustot et al.|Journal of Hepatology|2011Cited by 147